RecruitingNot ApplicableNCT07599072

PREdiabetes GLycemic Impact and Data Evaluation

Evaluation of the Impact of Continuous Glucose Monitoring (CGM) Systems on Glycemic Control in People With Prediabetes: Postmarketing Clinical Study

Sponsor

Nazarii Kobyliak

Enrollment

80 participants

Start Date

Jul 1, 2026

Study Type

INTERVENTIONAL

Conditions

Insulin Resistance Obesity, Overweight Pre-diabetic

Summary

This prospective, randomized controlled trial evaluates whether real-time continuous glucose monitoring (CGM) improves glycemic control and lifestyle adherence in adults with prediabetes compared to conventional self-monitoring methods over a 3-month period. By analyzing metabolic markers and behavioral data, the study aims to determine the effectiveness of 24-hour monitoring as a personalized tool that increases patient adherence to lifestyle changes compared to conventional SMBG methods.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called CGM Sibionics and a medical device called On-Call Extra Glucometer for people with insulin resistance, obesity, overweight, and other related conditions. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.